PharmaNet is a full-service contract research organization (CRO) dedicated to providing exceptional drug development services on a global basis.
With offices strategically placed throughout the US, Europe and Asia, we provide a complete range of Phase I-IV clinical development services including strategic planning, data management and biostatistics, medical writing, site management and regulatory affairs.
PharmaNet’s innovative use of the latest technologies provides efficiencies within the electronic process from data capture through global electronic regulatory submissions.
Additionally, PharmaNet offers a variety of clinical trial consulting services for all aspects of your pharmaceutical and biotechnology drug development activities including extended services relating to toxicology, chemistry and manufacturing, preclinical and clinical pharmacokinetics and the assessment of in-licensing candidates.
| Contact Details: |
| 504 Carnegie Center |
| Princeton |
| NJ |
| 08540-6242 |
| United States of America |
| Tel: | 609 951 6800 |
| Fax: | 609 514 0390 |
| Email: | lallen@pharmanet-cro.com |
| WWW: | www.pharmanet-cro.com/
|
|
Loading...
|
Recent Publications by PharmaNet Incorporated: |  |
[Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy]
Dehydroepiandrosterone (DHEA) and its sulfate metabolite (DHEAS) are the... | 19th July, 2008
| Slaska Akademia Medyczna w Katowicach, Klinika Chorob Wewnetrznych i
| Pol Merkur Lekarski. 2008 Jan;24(139):66-71.
|
[Commentary to the article: Wiviott S D, Braunwald E, McCabe C H et al. Prasugrel versus clopidogrel in patients with acute coronary syndromem. N Engl J Med 2007; 357: 2001-15]
Dehydroepiandrosterone (DHEA) and its sulfate metabolite (DHEAS) are the... | 19th July, 2008
| Samodzielna Pracownia Hemodynamiki, Instytut Kardiologii, Warszawa.
| Kardiol Pol. 2008 Feb;66(2):222-5; discussion 225-6.
|
Lack of a significant drug interaction between raltegravir and tenofovir.
Background: Raltegravir is a novel HIV-1 integrase inhibitor with potent... | 16th July, 2008
| Merck & Co., Inc., Whitehouse Station, New Jersey; Pharmanet Development
| Antimicrob Agents Chemother. 2008 Jul 14;.
DOI Direct Link |
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
The authors evaluate the human safety, tolerability, pharmacokinetics, and... | 20th May, 2008
| Pharmanet Development Group, Inc., Miami, Florida, USA.
| J Clin Pharmacol. 2008 Feb;48(2):193-202.
DOI Direct Link |
[Somatostatin analogs]
Hypothyroidism is a fairly common disease. The signs and symptoms of... | 16th May, 2008
| Katedra Farmakologii, Zaklad Farmakologii Klinicznej S1. AM w Katowicach.
| Pol Arch Med Wewn. 2006 Oct;116(4):988-97.
|
→View more PharmaNet Incorporated research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 26 individuals from PharmaNet Incorporated using this service.
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 343 times since April 2007, the link to the organisation's website has been followed 76 times
Recent Search Terms used to find this page: pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet-CRO | pharmanet | 14th february 2008 contact email addresses managing directors of companies in united state of america | Regulatory medical writing | pharmanet email | .
Search for more companies in Princeton
Search for more companies in NJ
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
PharmaNet Incorporated
